These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

211 related items for PubMed ID: 20416945

  • 1. New drugs in migraine treatment and prophylaxis: telcagepant and topiramate.
    Edvinsson L, Linde M.
    Lancet; 2010 Aug 21; 376(9741):645-55. PubMed ID: 20416945
    [Abstract] [Full Text] [Related]

  • 2. Telcagepant, a calcitonin gene-related peptide antagonist for the treatment of migraine.
    Tepper SJ, Cleves C.
    Curr Opin Investig Drugs; 2009 Jul 21; 10(7):711-20. PubMed ID: 19579177
    [Abstract] [Full Text] [Related]

  • 3. Efficacy and tolerability of MK-0974 (telcagepant), a new oral antagonist of calcitonin gene-related peptide receptor, compared with zolmitriptan for acute migraine: a randomised, placebo-controlled, parallel-treatment trial.
    Ho TW, Ferrari MD, Dodick DW, Galet V, Kost J, Fan X, Leibensperger H, Froman S, Assaid C, Lines C, Koppen H, Winner PK.
    Lancet; 2008 Dec 20; 372(9656):2115-23. PubMed ID: 19036425
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Antimigraine efficacy of telcagepant based on patient's historical triptan response.
    Ho TW, Olesen J, Dodick DW, Kost J, Lines C, Ferrari MD.
    Headache; 2011 Jan 20; 51(1):64-72. PubMed ID: 21054362
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Randomized, controlled study of telcagepant in patients with migraine and coronary artery disease.
    Ho TW, Ho AP, Chaitman BR, Johnson C, Mathew NT, Kost J, Fan X, Aurora SK, Brandes JL, Fei K, Beebe L, Lines C, Krucoff MW.
    Headache; 2012 Feb 20; 52(2):224-35. PubMed ID: 22221076
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Randomized controlled trial of the CGRP receptor antagonist telcagepant for migraine prevention.
    Ho TW, Connor KM, Zhang Y, Pearlman E, Koppenhaver J, Fan X, Lines C, Edvinsson L, Goadsby PJ, Michelson D.
    Neurology; 2014 Sep 09; 83(11):958-66. PubMed ID: 25107879
    [Abstract] [Full Text] [Related]

  • 10. Sustained pain freedom and no adverse events as an endpoint in clinical trials of acute migraine treatments: application to patient-level data from a trial of the CGRP receptor antagonist, telcagepant, and zolmitriptan.
    Dodick DW, Kost J, Assaid C, Lines C, Ho TW.
    Cephalalgia; 2011 Feb 09; 31(3):296-300. PubMed ID: 20937606
    [Abstract] [Full Text] [Related]

  • 11. Molecule of the month. Telcagepant.
    Drug News Perspect; 2009 Mar 09; 22(2):115. PubMed ID: 19330169
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Management of acute and chronic migraine.
    Coppola G, Schoenen J.
    Curr Opin Support Palliat Care; 2012 Jun 09; 6(2):177-82. PubMed ID: 22406987
    [Abstract] [Full Text] [Related]

  • 14. Comparison of the vasoconstrictor effects of the calcitonin gene-related peptide receptor antagonist telcagepant (MK-0974) and zolmitriptan in human isolated coronary arteries.
    Lynch JJ, Regan CP, Edvinsson L, Hargreaves RJ, Kane SA.
    J Cardiovasc Pharmacol; 2010 May 09; 55(5):518-21. PubMed ID: 20164785
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Effect of telcagepant on spontaneous ischemia in cardiovascular patients in a randomized study.
    Behm MO, Blanchard RL, Murphy MG, Palcza JS, Harris DE, Butterfield KL, Smith WB, Preston RA, Chodakewitz JA, Krucoff MW.
    Headache; 2011 Jun 09; 51(6):954-60. PubMed ID: 21631478
    [Abstract] [Full Text] [Related]

  • 18. Randomized, controlled trial of telcagepant for the acute treatment of migraine.
    Nardin R.
    Neurology; 2010 Mar 23; 74(12):1007; author reply 1007-8. PubMed ID: 20308688
    [No Abstract] [Full Text] [Related]

  • 19. Randomized, controlled trial of telcagepant over four migraine attacks.
    Ho AP, Dahlöf CG, Silberstein SD, Saper JR, Ashina M, Kost JT, Froman S, Leibensperger H, Lines CR, Ho TW.
    Cephalalgia; 2010 Dec 23; 30(12):1443-57. PubMed ID: 20974601
    [Abstract] [Full Text] [Related]

  • 20. Lack of hemodynamic interaction between CGRP-receptor antagonist telcagepant (MK-0974) and sumatriptan: results from a randomized study in patients with migraine.
    Depré M, Macleod C, Palcza J, Behm M, de Lepeleire I, Han T, Panebianco D, Smith W, Blanchard R, Chodakewitz J, Murphy M, de Hoon J.
    Cephalalgia; 2013 Dec 23; 33(16):1292-301. PubMed ID: 23798725
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.